WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins)

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Cumulative corticosteroid exposure

Cumulative steroid exposure will be modeled as cumulative dose (prednisone equivalent mg), cumulative days of exposure at any dose, cumulative days of exposure to doses ≥7.5mg and cumulative days of exposure to doses ≥20mg.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01616472 - WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins) | Biotech Hunter | Biotech Hunter